These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4139252)

  • 1. Effects of aldosterone antagonists on organ cultures of human prostatic tissue.
    Castro JE; Sellwood RA
    J Pathol; 1974 Aug; 113(4):217-22. PubMed ID: 4139252
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.
    Sadée W; Dagcioglu M; Schröder R
    J Pharmacol Exp Ther; 1973 Jun; 185(3):686-95. PubMed ID: 4712657
    [No Abstract]   [Full Text] [Related]  

  • 3. Benign hyperplasia of the human prostate exposed to steroid hormones in organ culture.
    Harbitz TB; Falkanger B; Sander S
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():89-93. PubMed ID: 4141577
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of spironolactone and canrenone on the digoxin radioimmunoassay.
    Huffman DH
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):787-90. PubMed ID: 4477402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histomorphometry study of the effect of an inhibitor of 5-alpha reductase on the coating of human prostate explants in tissue culture].
    López Muñoz A; Larrán Lopez J; Salido Peracaula M; Aparicio Patino J; Vilches Troya J
    Actas Urol Esp; 1998 Jan; 22(1):11-6. PubMed ID: 9580265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of aldosterone in normal subjects by Ro 12-2503 and spironolactone.
    Dux S; Rosenfeld J; Cocco G; Chu D; Gasser DF
    Arzneimittelforschung; 1982; 32(2):164-9. PubMed ID: 7199923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression by the spironolactone metabolite canrenone of plasma testosterone in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(4):403-6. PubMed ID: 4280523
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(4):395-401. PubMed ID: 4280522
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of stilbestrol on the metabolism of testosterone by benign prostatic hyperplasia in organ culture.
    McMahon MJ; Thomas GH
    Br J Surg; 1971 Nov; 58(11):869. PubMed ID: 4108125
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone regulation of human prostate in organ culture.
    Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM
    Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prostate growth in organ culture.
    Sandberg AA; Kadohama N
    Prog Clin Biol Res; 1980; 37():9-29. PubMed ID: 6155672
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiandrogen effects on canine prostatic secretion.
    Schoonees R; Reynoso G; De Klerk JN; Murphy GP
    Invest Urol; 1973 May; 10(6):434-7. PubMed ID: 4704168
    [No Abstract]   [Full Text] [Related]  

  • 13. Water and electrolyte tissue composition in burned rats under the effect of SC-14266.
    Bevilacqua RG; Gonçalez Y; Gonçalves EL
    Rev Bras Pesqui Med Biol; 1973; 6(1):11-6. PubMed ID: 4724466
    [No Abstract]   [Full Text] [Related]  

  • 14. [Canrenoate potassium in the treatment of hyperosmolar syndromes during resuscitation].
    Gasperi A; Domenichini E; Ruozi P; Bobbio-Pallavicini F
    Minerva Anestesiol; 1974 Sep; 40(9):448-54. PubMed ID: 4423734
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiandrogenic effect of spirolactones: different mechanisms of action (author's transl)].
    Mahoudeau JA; Corvol P; Valcke JC; Menard J; Bricaire H
    Ann Endocrinol (Paris); 1976; 37(1):57-8. PubMed ID: 1015793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ culture of benign, aging, and hyperplastic human prostate.
    Pretlow TG; Yang B; Pretlow TP
    Microsc Res Tech; 1995 Mar; 30(4):271-81. PubMed ID: 7541675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ culture of canine prostate.
    Herwig KR; Fischer TV; Burkel WE; Kahn RH
    Invest Urol; 1978 Jan; 15(4):291-4. PubMed ID: 627474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
    Lokeshwar BL; Selzer MG; Block NL; Gunja-Smith Z
    Cancer Res; 1993 Oct; 53(19):4493-8. PubMed ID: 7691397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of cyproterone on the rat prostate in organ culture.
    Santti RS; Johansson R
    Gynecol Invest; 1971; 2(1):276-81. PubMed ID: 5161487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.